Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dombret, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Houze, P; Deschamps, F; Dombret, H; Bousquet, B; Gourmel, B
      Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum

      JOURNAL OF CHROMATOGRAPHY B
    2. Sievers, EL; Larson, RA; Stadtmauer, EA; Estey, E; Lowenberg, B; Dombret, H; Karanes, C; Theobald, M; Bennett, JM; Sherman, ML; Berger, MS; Eten, CB; Loken, MR; van Dongen, JJM; Bernstein, ID; Appelbaum, FR
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    3. Fenaux, P; Chevret, S; Guerci, A; Fegueux, N; Dombret, H; Thomas, X; Sanz, M; Link, H; Maloisel, F; Gardin, C; Bordessoule, D; Stoppa, AM; Sadoun, A; Muus, P; Wandt, H; Mineur, P; Whittaker, JA; Fey, M; Daniel, MT; Castaigne, S; Degos, L
      Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

      LEUKEMIA
    4. Thomas, X; Dombret, H; Cordonnier, C; Pigneux, A; Gardin, C; Guerci, A; Vekhoff, A; Sadoun, A; Stamatoullas, A; Fegueux, N; Maloisel, F; Cahn, JY; Reman, O; Gratecos, N; Berthou, C; Huguet, F; Kotoucek, P; Travade, P; Buzyn, A; de Revel, T; Vilque, JP; Naccache, P; Chomienne, C; Degos, L; Fenaux, P
      Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

      LEUKEMIA
    5. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
      Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Adida, C; Recher, C; Raffoux, E; Daniel, MT; Taksin, AL; Rousselot, P; Sigaux, F; Degos, L; Altieri, DC; Dombret, H
      Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    7. Adida, C; Haioun, C; Gaulard, P; Lepage, E; Morel, P; Briere, J; Dombret, H; Reyes, F; Diebold, J; Gisselbrecht, C; Salles, G; Altieri, DC; Molina, TJ
      Prognostic significance of survivin expression in diffuse large B-cell lymphomas

      BLOOD
    8. Bastie, JN; Cazals-Hatem, D; Daniel, MT; D'Agay, MF; Rabian, CL; Glaisner, S; Noel-Walter, MP; Dabout, D; Flandrin, G; Dombret, H; Poisson, D; Degos, L; Castaigne, S
      Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment

      LEUKEMIA & LYMPHOMA
    9. Pautier, P; Devidas, A; Delmer, A; Dombret, H; Sutton, L; Zini, JM; Nedelec, G; Molina, T; Marolleau, JP; Brice, P
      Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature

      LEUKEMIA & LYMPHOMA
    10. Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, AM; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, JP; Archimbaud, E
      Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

      LEUKEMIA
    11. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
      A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia

      BLOOD
    12. Archimbaud, E; Ottmann, OG; Yin, JAL; Lechner, K; Dombret, H; Sanz, MA; Heil, G; Fenaux, P; Brugger, W; Barge, A; O'Brien-Ewen, C; Matcham, J; Hoelzer, D
      A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia

      BLOOD
    13. LUNDIN J; OSTERBORG A; BRITTINGER G; CROWTHER D; DOMBRET H; ENGERT A; EPENETOS A; GISSELBRECHT C; HUHN D; JAEGER U; THOMAS J; MARCUS R; NISSEN N; POYNTON C; RANKIN E; STAHEL R; UPPENKAMP M; WILLEMZE R; MELLSTEDT H
      CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY

      Journal of clinical oncology
    14. Dombret, H
      Granulocyte colony-stimulating factor in combination with intensive chemotherapy in the treatment of acute myeloid leukemia

      LEUKEMIA RESEARCH
    15. MAKKI J; TAKSIN A; ROUSSELOT P; LEBBE G; MICLEA JM; BENBUNAN M; DEGOS L; DOMBRET H
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS TREATED FOR ADVANCED MYELODYSPLASIA (A-MDS) OR HIGH-RISK ACUTE MYELOID-LEUKEMIA (HR-AML) - PARIS ST-LOUIS HOSPITALS EXPERIENCE

      British Journal of Haematology
    16. DOMBRET H; SAELAND S; ROUSSELOT P; CHAIBI P; DANIEL MT; GARDIN C; HUNAULT M; ZINI JM; TAKSIN AL; BONNAL C; DOSQUET C; TABAH I
      INTERLEUKIN-4 (IL-4) THERAPY IN REFRACTORY OR RELAPSING ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PHASE I-II STUDY

      British Journal of Haematology
    17. THOMAS X; CORDONNIER C; DOMBRET H; FEGUEUX N; MALOISEL F; VEKHOFF A; REMAN O; VILQUE JP; GRATECOS N; DEREVEL T; COASIN T; BUZYN A; CAHN JY; GUERCI A; CHOMIENNE C; ARCHIMBAUD E; DEGOS L; FENAUX P
      ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      British Journal of Haematology
    18. ARCHIMBAUD E; FENAUX P; DOMBRET H; DREYFUS F; TILLY H; CONYMAKHOUL P; LEBLOND V; TROUSSARD X; DELAIR S; FFRENCH M; MARIE JP
      GM-CSF TO INCREASE EFFICACY OF SEQUENTIAL CHEMOTHERAPY IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL (EMA91)

      British Journal of Haematology
    19. CASTAIGNE S; ARCHIMBAUD A; BORDESSOULE D; TILLY H; DOMBRET H; DEREVEL T; SIMON M; RENOUX M; JANVIER M; GROSBOIS M; DUPRIEZ B; ZINI JM; TERTIAN G; BAY O; FENAUX P; DEGOS L; CHASTANG C
      INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL

      British Journal of Haematology
    20. TAKSIN AL; THOMAS X; CASTAIGNE S; ROUSSELOT P; DEGOS L; ARCHIMBAUD E; DOMBRET H
      LIMITS FOR INTENSIFYING INDUCTION THERAPY IN YOUNGER PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML)

      British Journal of Haematology
    21. CHALIBI P; ROUSSELOT P; GLAISNER S; MOUAS H; TAKSIN AL; MICLEA JM; CASTAIGNE S; DEGOS L; DOMBRET H
      MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS OR MORE

      British Journal of Haematology
    22. DOMBRET H; THOMAS X; BLAISE D; HUGUET F; BOIRON JM; BUZYN A; STAMATOULAS A; DELANNOY A; BRADSTOCK K; BOUCHEIX C; CHARRIN C; GABERT J; LEBBE G; LHERITIER V; FIERE D
      INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/

      British Journal of Haematology
    23. ROUSSELOT P; ROMAN S; TAKSIN AL; DANIEL MT; ULLERN M; MICLEA JM; DOMBRET H; DEGOS L; JABLON L
      BIRDSHOT RETINOPATHY SIMULATING AN OCULAR LEUKEMIC RELAPSE

      British Journal of Haematology
    24. COSTELLO R; SAINTY D; FERMAND JP; DELMER A; DIVINE M; MAROLLEAU JP; GASTAUT JA; DOMBRET H; CHAIBI P
      PLASMA-CELL LEUKEMIA (PCL) - A MULTICENTRIC RETROSPECTIVE STUDY

      British Journal of Haematology
    25. DEBOTTON S; DOMBRET H; SANZ M; SANMIGUEL J; CAILLOT D; ZITTOUN R; GARDEMBAS M; STAMATOULAS A; CONDE E; GUERCI A; GARDIN C; GEISER K; MAKHOUL DC; REMAN O; DELASERNA J; LEFRERE F; CHOMIENNE C; CHASTANG C; DEGOS L; FENAUX P
      INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    26. MANSOURI S; DUBERTRET L; BASTUJIGARIN S; DOMBRET H; ROUJEAU JC; ARACTINGI S
      ROLE OF DRUGS IN CUTANEOUS ERUPTIONS AFTER CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA

      Archives of dermatology
    27. HOELZER D; HOFMANN WK; OTTMANN OG; DOMBRET H; HERRMANN F; GANSER A; KANZ L; FENAUX P; YIN JAL; LECHNER K; SANZ MA; ARCHIMBAUD E
      EFFECT OF PEG-RHU MGDF IN THE INDUCTION TREATMENT OF ACUTE MYELOID-LEUKEMIA

      European journal of cancer
    28. GARDIN C; CHAIBI P; DEREVEL T; ROUSSELOT P; TURLURE P; MICLEA JM; NEDELLEC G; DOMBRET H
      INTENSIVE CHEMOTHERAPY WITH IDARUBICIN, CYTOSINE-ARABINOSIDE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH SECONDARY AND THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA

      Leukemia
    29. DOMBRET H
      INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES

      Pathologie et biologie
    30. CHAIBI P; ROUSSELOT P; GLAISNER S; MOUAS H; MICLEA JM; CASTAIGNE S; DEGOS L; DOMBRET H
      MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS AND OVER - A SINGLE INSTITUTION EXPERIENCE

      Blood
    31. RECHER C; LARGHERO J; ROUSSELOT P; DASILVA N; MEYER S; MOUAS H; MICLEA JM; CHOMIENNE C; DOMBRET H; DEGOS L
      DEXAMETHASONE INDUCES IN-VITRO AND IN-VIVO APOPTOSIS OF LEUKEMIC-CELLS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA (AML) WITH THE T(8-21) TRANSLOCATION

      Blood
    32. FENAUX P; CHASTANG C; SANZ M; THOMAS X; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTOUN R; GARDIN C; MALOISEL F; FEY M; TRAVADE P; REIFFERS J; STAMATOULAS A; STOPPA AM; CAILLOT D; LEFRERE F; HAYAT M; CASTAIGNE S; CHOMIENNE C; DEGOS L
      ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL

      Blood
    33. STRYCKMANS P; SUCIU S; ANNINO L; SAGLIO G; MUUS P; MARIE JP; DOMBRET H; GAMBERT J; SOLBU G; DARDENNE M; MANDELLI F; FIERE D
      MOLECULAR EVALUATION OF CONSOLIDATION THERAPY AND EARLY ALLOGRAFT OR AUTOGRAFT FOR BCR-ABL(POS) ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS - A PILOT-STUDY OF EIGLE (EUROPEAN INTERGROUP OF GIMEMA, FRENCHLALA AND EORTC)

      Blood
    34. DEBOTTON S; DOMBRET H; SANZ M; SANMIGUEL J; CAILLOT D; ZITTOUN R; GARDEMBAS M; STAMATOULAS A; CONDE E; GUERCI A; GARDIN C; MAKHOUL DC; REMAN O; DELASERNA J; LEFRERE F; CHASTANG C; DEGOS L; FENAUX P
      CLINICAL-FEATURES AND OUTCOME OF ATRA SYNDROME IN A LARGE MULTICENTERTRIAL IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      Blood
    35. ARCHIMBAUD E; FENAUX P; DOMBRET H; DREYFUS F; TILLY H; CONYMAKHOUL P; LEBLOND V; TROUSSARD X; DELAIR S; FFRENCH M; MARIE JP
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) TO INCREASEEFFICACY OF INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH MITOXANTRONE(M), ETOPOSIDE(E) AND CYTARABINE(A) IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL

      Blood
    36. DASILVA N; MEYERMONARD S; MENOT ML; DEGOS L; BARUCHEL A; DOMBRET H; CHOMIENNE C
      G-CSF ACTIVATES STAT PATHWAYS IN KASUMI-1 MYELOID LEUKEMIC-CELLS WITHTHE T(8, 21) TRANSLOCATION - BASIS FOR POTENTIAL THERAPEUTIC EFFICACY

      Cytokines cellular & molecular therapy
    37. DOMBRET H
      GRANULOCYTIC COLONY-STIMULATING FACTORS IN THE MANAGEMENT OF PATIENTSWITH ACUTE MYELOID-LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    38. ARCHIMBAUD E; LEBLOND V; FENAUX P; DOMBRET H; CORDONNIER C; DREYFUS F; CONYMAKHOUL P; TILLY H; TROUSSARD X; AUZANNEAU G; THOMAS X; FFRENCH M; MARIE JP
      TIMED SEQUENTIAL CHEMOTHERAPY FOR ADVANCED ACUTE MYELOID-LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    39. BRICE P; MAROLLEAU JP; PAUTIER P; MAKKE J; CAZALS D; DOMBRET H; DAGAY MF; BENBUNAN M; GISSELBRECHT C
      HEMATOLOGIC RECOVERY AND SURVIVAL OF LYMPHOMA PATIENTS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - COMPARISON OF BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR CELLS

      Leukemia & lymphoma
    40. SEALE J; DELVA L; RENESTO P; BALITRAND N; DOMBRET H; SCROBOHACI ML; DEGOS L; PAUL P; CHOMIENNE C
      ALL-TRANS-RETINOIC ACID RAPIDLY DECREASES CATHEPSIN-G SYNTHESIS AND MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    41. DOMBRET H; FONT MP; SIGAUX F
      A DOMINANT TRANSCRIPTIONAL SILENCER LOCATED 5' TO THE HUMAN T-CELL RECEPTOR-V-BETA-2.2 GENE SEGMENT WHICH IS ACTIVATED IN CELL-LINES OF THYMIC PHENOTYPE

      Nucleic acids research
    42. DASILVA N; BASTIE JN; BALITRAND N; ZASSADOWSKI F; DOMBRET H; DEGOS L; CHOMIENNE C
      G-CSF INDUCED STAT1 AND STAT3 KINETICS OF ACTIVATION ARE NORMAL IN G-CSF SENSITIVE T(8-21) AML CELLS

      Blood
    43. DOMBRET H; SAELAND S; LAFONTAINE C; ROUSSELOT P; CHAIBI P; TABAH I; DEGOS L
      ACUTE TUMOR LYSIS SYNDROME UNDER IL-4 THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      Blood
    44. FENAUX P; CHASTANG C; SANZ M; ARCHIMBAUD E; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTTOUN R; GARDIN C; MALOSIEL F; FEY M; CASTAIGNE S; CHOMIENNE C; DEGOS L
      EFFECT OF ATRA IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - VALIDATION OF SHORT-TERM EFFECT IN A LARGE MULTICENTER TRIAL (APL-93TRIAL) AND ASSESSMENT OF LONG-TERM BENEFIT (APL-91 TRIAL)

      Blood
    45. DOMBRET H; GABERT J; MACINTYRE E; CAYUELA JM; CHARRIN C; THOMAS X; STOPPA AM; VEIL A; TILLY H; REIFFERS J; ATTAL M; DELANNOY A; BOUCHEIX C; RACADOT E; MICLEA JM; BLAISE D; VERNANT JP; LHERITIER V; FIERE D
      26 PERCENT OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ENROLLED IN A MULTICENTER TRIAL HAVE BCR-ABL LEUKEMIA AND HALF OF THEMCAN RECEIVE A STEM-CELL TRANSPLANTATION (SCT)

      Blood
    46. ARCHIMBAUD E; OTTMANN O; YIN JAL; LECHNER K; DOMBRET H; SANZ MA; HERRMANN F; GRUSS H; FENAUX P; GANSER A; HEIL G; KANZ L; BRUGGER W; SIMS T; OLSEN K; HOELZER D
      A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY USING PEG-RHUMGDF AS AN ADJUNCT TO CHEMOTHERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - EARLY RESULTS

      Blood
    47. DOMBRET H; GEIGER S; DANIEL MT; GLAISNER S; MICLEA JM; CASTAIGNE S; MERLEBERAL H; LACOMBE C; CHOMIENNE C; DEGOS L
      CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURINGALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS

      Leukemia
    48. HUNAULT M; DOMBRET H; GARDIN C; RIO B; HERMINE O; BRICE P; DEVIDAS A; TURLURE P; ZINI JM; NEDELLEC G; SUTTON L; MICLEA JM; DEREVEL T; DUPUY E; PAUTIER P; MAROLLEAU JP; DELMER A
      HEMATOPOIETIC GROWTH-FACTORS IN DRUG-INDUCED AGRANULOCYTOSIS

      Leukemia
    49. DOMBRET H; SCROBOHACI ML; DANIEL MT; MICLEA JM; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
      IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Leukemia
    50. SCROBOHACI ML; DOMBRET H; DANIEL MT; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
      IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Thrombosis and haemostasis
    51. LIOTE F; PERTUISET E; COCHANDPRIOLLET B; DAGAY MF; DOMBRET H; NUMERIC P; DANGLEJAN G; KUNTZ D
      METHOTREXATE RELATED B-LYMPHOPROLIFERATIVE DISEASE IN A PATIENT WITH RHEUMATOID-ARTHRITIS - ROLE OF EPSTEIN-BARR-VIRUS INFECTION

      Journal of rheumatology
    52. AZAGURY M; DOMBRET H; CASTAIGNE S; DEGOS L
      GROWTH-HORMONE AND ACUTE PROMYELOCYTIC LEUKEMIA

      Medical and pediatric oncology
    53. DOMBRET H; MAROLLEAU JP
      DE-NOVO ACUTE MYELOID-LEUKEMIA IN PATIENTS WITH CROHNS-DISEASE

      Nouvelle revue francaise d'hematologie
    54. DOMBRET H; CHASTANG C
      RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA - REPLY

      The New England journal of medicine
    55. DOMBRET H; CHASTANG C; FENAUX P; REIFFERS J; BORDESSOULE D; BOUABDALLAH R; MANDELLI F; FERRANT A; AUZANNEAU G; TILLY H; YVER A; DEGOS L
      A CONTROLLED-STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS AFTER TREATMENT FOR ACUTE MYELOGENOUS LEUKEMIA

      The New England journal of medicine
    56. JOURDAN E; DOMBRET H; GLAISNER S; MICLEA JM; CASTAIGNE S; DEGOS L
      UNEXPECTED HIGH-INCIDENCE OF INTRACRANIAL SUBDURAL-HEMATOMA DURING INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA WITH A MONOBLASTIC COMPONENT

      British Journal of Haematology
    57. CHAIBI P; GARDIN C; DEREVEL T; ROUSSELOT P; TURLURE P; KULEKCISAUVAGE C; VEIL A; SUTTON L; MICLEA JM; NEDELLEC G; DOMBRET H
      INTENSIVE CHEMOTHERAPY WITH IDARUBICIN, CYTOSINE-ARABINOSIDE, AND G-CSF IN PATIENTS WITH SECONDARY AND THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA

      Blood
    58. PAUTIER P; DEVIDAS A; MOLINA T; ZINI JM; DELMER A; DEREVEL T; SUTTON L; DOMBRET H; MICLEA JM; NEDELEC G; TURLURE P; BRICE P
      ANGIOIMMUNOBLASTIC LYMPHADENOPATHY-TYPE T-CELL LYMPHOMA (AILS-TNHL) -CLINICAL-FEATURES AND TREATMENT - REVIEW OF 31 PATIENTS

      Blood
    59. DOMBRET H; DANIEL MT; CHAIBI P; ROUSSELOT P; JONVEAUX P; CHOMIENNE C; DEGOS L
      IN-VIVO ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ENHANCES THE GRANULOCYTIC MATURATION OF LEUKEMIC-CELLS IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) AND THE T(8-21) TRANSLOCATION

      Blood
    60. SUTTON L; LORTHOLARY O; RIO B; DHEDIN N; BOUABDALLAH R; DOMBRET H; FOUILLARD L; THOMAS X; WITZ B; CASASSUS P
      ACUTE MYELOID-LEUKEMIA IN HIV-POSITIVE PATIENTS - RESPONSE TO CONVENTIONAL CHEMOTHERAPY

      Blood
    61. DEGOS L; DOMBRET H; CHOMIENNE C; DANIEL MT; MICLEA JM; CHASTANG C; CASTAIGNE S; FENAUX P
      ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATING AGENT IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    62. ARACTINGI S; MALLET V; PINQUIER L; CHOSIDOW O; VIGNONPENNAMEN MD; DEGOS L; DUBERTRET L; DOMBRET H
      NEUTROPHILIC DERMATOSES DURING GRANULOCYTOPENIA

      Archives of dermatology
    63. DOMBRET H; CASTAIGNE S; FENAUX P; CHOMIENNE C; DEGOS L
      INDUCTION TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA USING ALL-TRANS-RETINOIC ACID - CONTROVERSIES ABOUT DOSAGE, ADVANTAGES AND SIDE-EFFECT MANAGEMENT

      Leukemia
    64. GEIGER S; DOMBRET H; BUCHERER C; LACOMBE C; LELIEVRE JC
      MICRORHEOLOGY OF MARROW PROMYELOCYTIC CEL LS FORM PATIENTS SUFFERING OF ACUTE MYELOID TYPE-3 LEUKEMIA

      Journal des maladies vasculaires
    65. ARCHIMBAUD E; LEBLOND V; FENAUX P; DOMBRET H; CORDONNIER C; CONYMAKOUL P; DREYFUS F; TROUSSARD X; AUZANNEAU G; STOPPA AM; SIMON M; FRENCH M; MARIE JP
      SEQUENTIAL CHEMOTHERAPY WITH OR WITHOUT G M-CSF (GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR) IN ADVANCED ACUTE MYELOID-LEUKEMIA - CURRENT STATUS OF THE EMA86 AND EMA91 PROTOCOLS

      Nouvelle revue francaise d'hematologie
    66. ARACTINGI S; BACHMEYER C; DOMBRET H; VIGNONPENNAMEN D; DEGOS L; DUBERTRET L
      SIMULTANEOUS OCCURRENCE OF 2 RARE CUTANEOUS MARKERS OF POOR-PROGNOSISIN MYELODYSPLASTIC-SYNDROME - ERYTHEMA-ELEVATUM-DIUTINUM AND SPECIFICLESIONS

      British journal of dermatology
    67. DOMBRET H; YVER A; CHASTANG C; DEGOS L
      INCREASED FREQUENCY OF COMPLETE REMISSION BY LENOGRASTIM RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) ADMINISTRATION AFTER INTENSIVE INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTS WITH DE-NOVOACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A RANDOMIZED MULTICENTER DOUBLE-BLIND CONTROLLED-STUDY

      Blood
    68. HUNAULT M; BRICE P; TURLURE P; ZINI JM; DEVIDAS A; NEDELEC G; SUTTON L; MAROLLEAU JP; GARDIN C; DEREVEL T; DUPUY E; PAUTIER P; MICLEA JM; DOMBRET H; DELMER A
      MANTLE CELL LYMPHOMA (MCL) - CLINICAL-FEATURES AND TREATMENT RESULTS IN 42 PATIENTS

      Blood
    69. LEBLOND V; SALEHIAN BD; BOREL C; MAPAKOU CP; DOMBRET H; SUTTON L; BINET JL; ANKRI A
      ALTERATIONS IN NATURAL ANTICOAGULANT LEVELS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A PROSPECTIVE-STUDY IN 27 PATIENTS

      Bone marrow transplantation
    70. CASTAIGNE S; LEFEBVRE P; CHOMIENNE C; SUC E; RIGALHUGUET F; GARDIN C; DELMER A; ARCHIMBAUD E; TILLY H; JANVIER M; ISNARD F; TRAVADE P; MONTFORT L; DELANNOY A; RAPP MJ; CHRISTIAN B; MONTASTRUC M; WEH H; FENAUX P; DOMBRET H; GOURMEL B; DEGOS L
      EFFECTIVENESS AND PHARMACOKINETICS OF LOW-DOSE ALL-TRANS-RETINOIC ACID (25 MG M2) IN ACUTE PROMYELOCYTIC LEUKEMIA/

      Blood
    71. FENAUX P; LEDELEY MC; CASTAIGNE S; ARCHIMBAUD E; CHOMIENNE C; LINK H; GUERCI A; DUARTE M; DANIEL MT; BOWEN D; HUEBNER G; BAUTERS F; FEGUEUX N; FEY M; SANZ M; LOWENBERG B; MALOISEL F; AUZANNEAU G; SADOUN A; GARDIN C; BASTION Y; GANSER A; JACKY E; DOMBRET H; CHASTANG C; DEGOS L
      EFFECT OF ALL TRANSRETINOIC ACID IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF A MULTICENTER RANDOMIZED TRIAL

      Blood
    72. DOMBRET H; RENESTO P; SCROBOHACI ML; GUERCI AP; BARUCHEL A; MOLINA L; RAPP MJ; CORDONNIER C; CASTAIGNE S; DEGOS L
      PLASMA-FREE SERINE-PROTEASE ACTIVITY (SPA) IN PATIENTS WITH ACUTE PRMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY

      Blood
    73. DOMBRET H; TOUBERT ME; SCHLAGETER MH; CHOMIENNE C; DEGOS L
      GRANULOCYTIC COLONY-STIMULATING FACTORS (G-CSF AND GM-CSF) IN THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA

      Nouvelle revue francaise d'hematologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 23:34:16